Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A high throughput beta-globin genotyping method by multiplexed melting temperature analysis.

Zhili Lin1, Joseph G Suzow, Jamie M Fontaine

  • 1Pediatrix Screening, Inc., 90 Emerson Lane, Suite 1403, Bridgeville, PA 15017, USA. Zhili_Lin@pediatrix.com

Molecular Genetics and Metabolism
|February 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synergizing a knowledge graph and large language model for relay catalysis pathway recommendation.

National science review·2025
Same author

Comprehensive analysis of exosome-related gene signature in multiple myeloma prognosis and immune microenvironment evaluation.

Cancer immunology, immunotherapy : CII·2025
Same author

Leveraging a disulfidptosis-based signature to characterize heterogeneity and optimize treatment in multiple myeloma.

Frontiers in immunology·2025
Same author

OAM-basis underwater single-pixel imaging based on deep learning at a low sampling rate.

Optics express·2025
Same author

Identification and validation of a platelet-related signature for predicting survival and drug sensitivity in multiple myeloma.

Frontiers in pharmacology·2024
Same author

Prognostic significance of β2-microglobulin decline index in multiple myeloma.

Frontiers in oncology·2024

A new genotyping method accurately screens for common beta-globin gene mutations in newborns. This high-throughput system improves newborn screening quality and efficiency for genetic disorders.

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Population-based newborn screening programs face challenges in integrating technological advancements for improved quality, efficiency, and diagnostic capabilities.
  • Screening for beta-globin gene mutations is crucial for identifying hemoglobinopathies.

Purpose of the Study:

  • To describe a newly developed, high-throughput genotyping method for screening common beta-globin gene mutations.
  • To enhance the efficiency and accuracy of newborn screening for genetic disorders.

Main Methods:

  • A genotyping system combining automation for DNA extraction and PCR setup, a thermal cycler, and a LightTyper instrument for melting temperature analysis.
  • Utilized asymmetric PCR with fluorescently labeled probes and FRET analysis for simultaneous detection of three common beta-globin mutations (S, C, E).

Related Experiment Videos

  • Validated the assay using a large sample set, comparing results to isoelectric focusing electrophoresis.

    • Main Results:

    • The assay can simultaneously detect three common beta-globin mutations and identify eight possible genotypes (AA, AE, EE, AS, SC, SS, AC, CC) in a single reaction.
    • The genotyping method demonstrated high accuracy, exceeding 99% when validated against isoelectric focusing electrophoresis.
    • The integrated system streamlines the process from DNA extraction to genotyping, reducing post-PCR handling.

    Conclusions:

    • The developed genotyping method offers a highly accurate and efficient approach for population-based newborn screening of beta-globin gene mutations.
    • This technological advancement has the potential to significantly improve the quality and diagnostic capabilities of existing newborn screening programs.
    • The system's high throughput and accuracy make it suitable for widespread implementation in public health initiatives for hemoglobinopathies.